Your browser doesn't support javascript.
loading
HU-910, a CB2 receptor agonist, reverses behavioral changes in pharmacological rodent models for schizophrenia.
Cortez, Isadora Lopes; Silva, Nicole R; Rodrigues, Naielly S; Pedrazzi, João Francisco C; Del Bel, Elaine A; Mechoulam, Raphael; Gomes, Felipe V; Guimarães, Francisco S.
Afiliação
  • Cortez IL; Department of Pharmacology, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto, SP, Brazil. Electronic address: isalopescortez@gmail.com.
  • Silva NR; Department of Pharmacology, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto, SP, Brazil.
  • Rodrigues NS; Department of Pharmacology, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto, SP, Brazil.
  • Pedrazzi JFC; Department of Physiology, Ribeirão Preto Dentistry School, University of São Paulo, Brazil.
  • Del Bel EA; Department of Physiology, Ribeirão Preto Dentistry School, University of São Paulo, Brazil.
  • Mechoulam R; Department of Medicinal Chemistry and Natural Products, Hebrew University Medical Faculty, Jerusalem, Israel.
  • Gomes FV; Department of Pharmacology, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto, SP, Brazil.
  • Guimarães FS; Department of Pharmacology, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto, SP, Brazil.
Prog Neuropsychopharmacol Biol Psychiatry ; 117: 110553, 2022 07 13.
Article em En | MEDLINE | ID: mdl-35341823
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Esquizofrenia / Canabinoides Limite: Animals / Humans / Male Idioma: En Revista: Prog Neuropsychopharmacol Biol Psychiatry Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Esquizofrenia / Canabinoides Limite: Animals / Humans / Male Idioma: En Revista: Prog Neuropsychopharmacol Biol Psychiatry Ano de publicação: 2022 Tipo de documento: Article